Rizzo, A.; Cusmai, A.; Massafra, R.; Bove, S.; Comes, M.C.; Fanizzi, A.; Rinaldi, L.; Acquafredda, S.; Gadaleta-Caldarola, G.; Oreste, D.;
et al. Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis. Cells 2022, 11, 1857.
https://doi.org/10.3390/cells11121857
AMA Style
Rizzo A, Cusmai A, Massafra R, Bove S, Comes MC, Fanizzi A, Rinaldi L, Acquafredda S, Gadaleta-Caldarola G, Oreste D,
et al. Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis. Cells. 2022; 11(12):1857.
https://doi.org/10.3390/cells11121857
Chicago/Turabian Style
Rizzo, Alessandro, Antonio Cusmai, Raffaella Massafra, Samantha Bove, Maria Colomba Comes, Annarita Fanizzi, Lucia Rinaldi, Silvana Acquafredda, Gennaro Gadaleta-Caldarola, Donato Oreste,
and et al. 2022. "Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis" Cells 11, no. 12: 1857.
https://doi.org/10.3390/cells11121857
APA Style
Rizzo, A., Cusmai, A., Massafra, R., Bove, S., Comes, M. C., Fanizzi, A., Rinaldi, L., Acquafredda, S., Gadaleta-Caldarola, G., Oreste, D., Zito, A., Giotta, F., Lorusso, V., & Palmiotti, G.
(2022). Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis. Cells, 11(12), 1857.
https://doi.org/10.3390/cells11121857
